ANVISA claims for psychobiotic

Probiotic combination of L. helveticus Rosell®-52 and B. longum Rosell®-175, first to be recognized for its specific benefits in stressed healthy adults…

Brain-Gut Axis : new post-hoc analysis looking at appetite

  Probio’Stick® (LHS proprietary combination of Lactobacillus helveticus Rosell®-52 and Bifidobacterium longum Rosell®-175) is the most documented probiotic for the Brain-Gut Axis,…

Meet us at Probiota Americas June 24-26 Vancouver

Meet our Probiotics Experts at Probiota Americas  Lallemand Health Solutions is pleased to support once again the Probiota Americas conference as Gold…

SciEx 2019 to Feature New Scientific Discoveries and Advances in Probiotics

­­­ ­­­ Montreal, Canada (February 20, 2019) The Rosell® Institute for Microbiome and Probiotics, Lallemand Health Solutions’ integrated research unit, is proud…

Lallemand Health Solutions and ComboCap® Inc., announce exclusive partnership.

  The companies to launch an innovative new global probiotics product category using dual chamber capsule technology.   Montreal, Canada Lallemand Health Solutions, a…

Visit Lallemand Health Solutions at Probiota Global 2019

Montreal, Canada (February 8, 2019) Lallemand Health Solutions, a pioneer in probiotic solutions, is proud to be a Gold sponsor and roundtable…

Large meta-analysis backs probiotic benefits in gut health

Focused analysis of 53 Chinese clinical trials shows the efficacy of probiotic formula Medilac-S as adjuvant treatment in ulcerative colitis and prevention…

LAFTI L10 in oxidative stress

New results published on LAFTI® L10 in athletes Show a positive effect on antioxidant status and interesting results on LDL-cholesterol Investigating the…

Probio’stick in a neuroinflammation rat model

Promising study on Probio’Stick in a neuroinflammation model in rodents In recent years, the brain-gut axis has gained momentum with the discovery of…